Genetics Advances Offer Hope in Treatment of Hypertension

Julie A. Johnson

/kidneynews/5_10_11/32/graphic/32f1.jpg

The potential for using genetics to guide hypertension therapy will be the subject of a state-of-the-art lecture on Nov. 10. Julie A. Johnson, PharmD, will describe advances in hypertension pharmacogenomics.

Dr. Johnson is the V. Ravi Chandran Professor of Pharmaceutical Sciences and distinguished professor of pharmacy and medicine at the University of Florida Colleges of Pharmacy and Medicine. She is also director of the Center for Pharmacogenomics and director of the Shands Personalized Medicine Program at the University of Florida.

Dr. Johnson is a leader in the field of cardiovascular pharmacogenomics, having published more than 200 peer-reviewed publications. She leads a research group focused on pharmacogenomics of antihypertensive drugs as part of the National Institutes of Health (NIH)-supported Pharmacogenomics Research Network. She also leads the University of Florida’s effort in clinical translation of pharmacogenomics, which launched its clinical implementation program in June 2012.

Dr. Johnson has served on the Nonprescription Drugs Advisory Committee of the Food and Drug Administration, the Xenobiotic and Nutrient Disposition and Action Study Section at NIH as well as the National Heart, Lung, and Blood Institute’s Pediatric Heart Network Protocol Review Committee and Heart Failure Network Data Safety Monitoring Board. She was also a member of the American Heart Association committee on scientific sessions programming and co-chair of the 2009 International Congress on Genetics and Genomics of Cardiovascular Disease. She has had numerous other leadership roles in a variety of national organizations.

She is on the editorial boards of Clinical Pharmacology and Therapeutics, Pharmacogenetics and Genomics, Journal of the American Heart Association, Psychosomatic Medicine, and Pharmacogenomics.

Before joining the faculty at the University of Florida in 1998, Dr. Johnson spent 9 years on the faculty of the University of Tennessee College of Pharmacy. She received her bachelor’s degree in pharmacy from the Ohio State University and her PharmD from the University of Texas at Austin and the University of Texas Health Science Center at San Antonio.

Dr. Johnson has received numerous awards including teaching awards from the University of Tennessee and the University of Florida, the Ohio State University Alumni Association William Oxley Thompson Award for early career achievement, the Young Investigator Award from the American Society for Clinical Pharmacology and Therapeutics, the Distinguished Alumnus Award from the Ohio State University College of Pharmacy, the Paul Dawson Biotechnology Research Award from the American Association of Colleges of Pharmacy, and a therapeutic frontiers award and award for contributions to the literature from the American College of Clinical Pharmacy.